Bentley Systems Bolsters Cesium with Reality Modeling Capabilities, Brings Geospatial Context to Infrastructure Engineering
15.10.2025 10:50:00 EEST | Business Wire | Press release
(Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. It also unveiled geospatial capabilities for project delivery and asset performance and a new immersive engagement application for infrastructure teams and stakeholders, all powered by Cesium.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251015286327/en/
Bentley announced the availability of reality modeling services in Cesium, advancing its open platform for the built and natural environment. (Image courtesy of Bentley Systems)
Since acquiring Cesium a year ago, Bentley has made significant progress in integrating technologies from both companies, powering its own products and empowering developers to build applications that visualize infrastructure data in real time and in full geospatial context.
“Our vision for infrastructure engineering is built on openness,” said Patrick Cozzi, Bentley’s chief platform officer. “With the integration of iTwin and Cesium capabilities, we are creating the open platform for the built and natural environment—providing all the necessary data for infrastructure professionals to design, build, and operate in a real-world context.”
Adding reality modeling and AI-powered analysis to Cesium
Bentley has added reality modeling services from iTwin Capture to Cesium ion, creating a complete, automated pipeline from data capture through geospatial visualization. iTwin Capture creates engineering-grade reality models from imagery and applies AI-powered feature detection, while Cesium ion allows developers to create and host content in the cloud to power 3D geospatial applications.
With the new reality modeling capabilities, Cesium ion can create detailed 3D visualizations—reality meshes, point clouds, and Gaussian splats—directly from imagery, annotated by AI, ready to stream within applications using open standards. Creating an accurate, engineering-grade digital model of the existing built and natural environment and offering it as rich 3D geospatial context allows infrastructure professionals to make better informed decisions throughout the infrastructure lifecycle.
"Being able to generate photogrammetry, point clouds, and Gaussian splats as 3D Tiles from drone imagery, stream them seamlessly to the web, and analyze the point clouds is a major milestone,” said Osarodion Victory Igbinobaro, co-founder and CEO of AERO AI, a Cesium user. “This release brings end-to-end 3D reality modeling into one accessible, high-performance pipeline.”
The reality modeling capabilities in Cesium ion will be generally available before the end of 2025.
Enhancing project delivery and asset performance with geospatial context
Cesium capabilities are also enhancing Bentley’s product portfolio, bringing geospatial context to Bentley Open Applications and Bentley Infrastructure Cloud.
MicroStation 2025, the latest release of Bentley’s CAD software for infrastructure design, introduces support for 3D Tiles via Cesium. Engineers can now seamlessly integrate any 3D Tiles content, including Google Photorealistic 3D Tiles and their own high-fidelity reality data, directly into their design projects. This reduces the need to manually model existing conditions, accelerating project setup and allowing teams to focus on designing solutions. These same capabilities are coming to Bentley Open Applications built on MicroStation, for designing roads, railways, bridges, and more.
Cesium is also powering the geospatial experience in Bentley Infrastructure Cloud Connect, Bentley’s unified environment to connect data and people across the infrastructure lifecycle. With this geospatial context, also featuring Google Photorealistic 3D Tiles, users can navigate more intuitively across and within their projects and assets available in Bentley Infrastructure Cloud.
Introducing iTwin Engage
Bentley also announced iTwin Engage, which enables infrastructure teams and their stakeholders to engage immersively with digital twins of future and existing infrastructure assets.
Engineers often need to create immersive, photorealistic renderings to present their design work. Traditionally, this process is slow and inefficient, requiring specialized skills and resulting in static visuals that quickly become outdated as the design models evolve. With iTwin Engage, powered by Cesium and game engine technology, anyone can build impactful, narrative-driven content that brings projects and assets to life. Experiences are automatically generated, always current thanks to a live connection to the digital twin, and interactive—enabling not only design reviews, but also digital rehearsals for construction, immersive remote inspections, and more.
“The opportunity to present and communicate the project plan through iTwin Engage, in such an appealing manner, is fantastic,” said Simon Beards, principal planner, Laing O’Rourke, a participant in an early access program. “The greater the involvement the team has on the plan, the more likely there is a chance of success, as it supports a more collaborative way of engineering improvements.”
iTwin Engage will be in limited availability by the end of 2025.
# # #
About Bentley Systems
Around the world, infrastructure professionals rely on software from Bentley Systems to help them design, build, and operate better and more resilient infrastructure for transportation, water, energy, cities, and more. Founded in 1984 by engineers for engineers, Bentley is the partner of choice for engineering firms and owner-operators worldwide, with software that spans engineering disciplines, industry sectors, and all phases of the infrastructure lifecycle. Through our digital twin solutions, we help infrastructure professionals unlock the value of their data to transform project delivery and asset performance.
© 2025 Bentley Systems, Incorporated. Bentley, the Bentley logo, Cesium, Cesium ion, 3D Tiles, iTwin, Bentley Infrastructure Cloud, MicroStation, Bentley Open Applications, iTwin Capture, and iTwin Engage are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251015286327/en/
Contacts
For more information, contact:
Bentley Press: Chris Phillips, PR@news.bentley.com
Bentley Investors: Eric Boyer, IR@bentley.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom